Bladder cancer
Bladder cancer is the most common malignant tumor of the urinary system, and its incidence rate ranks first among malignant tumors of the urinary system. The cause of the disease is still unclear, but it is generally believed to be related to frequent contact with carcinogens such as naphthylamine and benzidine. Dyes, rubber, plastic products, paints, detergents, etc. commonly seen in daily life also have potential carcinogenic risks. Smoking is not only harmful to the respiratory system, but also causes bladder cancer. In addition, certain diseases such as leukoplakia, glandular cystitis, urethral stones, and urine retention may also induce bladder cancer. The incidence rate of bladder cancer in men and women is about 5:2, and there are about 54,500 new cases in the United States each year (estimated in 1997).
Related Drugs
Recombinant human interleukin-2 (125Ala) for injection
Indication: 1. It is used for the treatment of malignant tumors such as renal cell carcinoma, melanoma, breast cancer, bladder cancer, liver cancer, colorectal cancer, lymphoma, lung cancer, etc., and for the control of cancerous pleural effusion and ascites. It can also be used for the cultivation of lymphokine-activated killer cells.
Manufacturer:
Beijing SL Pharmaceutical Co., Ltd.
Recombinant human interleukin-2 (125Ala) for injection
Indication: 1. It is used for the treatment of malignant tumors such as renal cell carcinoma, melanoma, breast cancer, bladder cancer, liver cancer, colorectal cancer, lymphoma, lung cancer, etc., and for the control of cancerous pleural effusion and ascites. It can also be used for the cultivation of lymphokine-activated killer cells.
Manufacturer:
Beijing SL Pharmaceutical Co., Ltd.
Recombinant human interleukin-2 (125Ala) for injection
Indication: 1. It is used for the treatment of malignant tumors such as renal cell carcinoma, melanoma, breast cancer, bladder cancer, liver cancer, colorectal cancer, lymphoma, lung cancer, etc., and for the control of cancerous pleural effusion and ascites. It can also be used for the cultivation of lymphokine-activated killer cells.
Manufacturer:
Beijing SL Pharmaceutical Co., Ltd.
Recombinant human interleukin-2 (125Ala) for injection
Indication: 1. It is used for the treatment of malignant tumors such as renal cell carcinoma, melanoma, breast cancer, bladder cancer, liver cancer, colorectal cancer, lymphoma, lung cancer, etc., and for the control of cancerous pleural effusion and ascites. It can also be used for the cultivation of lymphokine-activated killer cells.
Manufacturer:
Beijing SL Pharmaceutical Co., Ltd.
Carboplatin for injection
Indication: It is mainly used for ovarian cancer, small cell lung cancer, non-small cell lung cancer, head and neck squamous cell carcinoma, esophageal cancer, seminoma, bladder cancer, mesothelioma, etc.
Manufacturer:
Yunnan Phyto Pharmaceutical Co., Ltd.
Carboplatin for injection
Indication: It is mainly used for ovarian cancer, small cell lung cancer, non-small cell lung cancer, head and neck squamous cell carcinoma, esophageal cancer, seminoma, bladder cancer, mesothelioma, etc.
Manufacturer:
Yunnan Phyto Pharmaceutical Co., Ltd.
Tegafur Tablets
Indication: It is mainly used to treat digestive tract tumors, and has certain effects on gastric cancer, colon cancer, and rectal cancer. It can also be used to treat breast cancer, bronchial lung cancer, liver cancer, etc. It can also be used for bladder cancer, prostate cancer, kidney cancer, etc.
Tegafur Tablets
Indication: It is mainly used to treat digestive tract tumors, and has certain effects on gastric cancer, colon cancer, and rectal cancer. It can also be used to treat breast cancer, bronchial lung cancer, liver cancer, etc. It can also be used for bladder cancer, prostate cancer, kidney cancer, etc.
Tegafur Tablets
Indication: It is mainly used to treat digestive tract tumors, and has certain effects on gastric cancer, colon cancer, and rectal cancer. It can also be used to treat breast cancer, bronchial lung cancer, liver cancer, etc. It can also be used for bladder cancer, prostate cancer, kidney cancer, etc.
Manufacturer:
Tonghua Mao Xiang Pharmaceutical Co., Ltd.
Tegafur Tablets
Indication: It is mainly used to treat digestive tract tumors, and has certain effects on gastric cancer, colon cancer, and rectal cancer. It can also be used to treat breast cancer, bronchial lung cancer, liver cancer, etc. It can also be used for bladder cancer, prostate cancer, kidney cancer, etc.
Manufacturer:
Hebei BRIC Pharmaceutical Co., Ltd.